November 27, 2019
Orexo acquires exclusive US rights to commercialize vorvida®, a digital therapy for alcohol use disorder with scientifically proven efficacy
Media
November 19, 2019
Interim Report Q3 2019
November 19, 2019
Nordic Nanovector ASA – Results for the Third Quarter 2019
November 18, 2019
Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director
November 13, 2019
Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
November 13, 2019
Vicore Pharma has completed a directed share issue of approximately SEK 125 million
November 12, 2019
BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW
November 12, 2019
Strongbridge Biopharma plc to Present at Two Upcoming Investor Conferences
November 11, 2019
Presentation of ONCOS-102 melanoma data at SITC Annual Meeting
November 11, 2019
GOLD’s evidence “A” rating affirms that endobronchial valves, like the Zephyr Valve, are a proven, viable, minimally-invasive treatment option for severe emphysema, a form of COPD
